🇺🇸 FDA
Pipeline program

Excipients without active substance - Lyophilised powder for solution for injection - Intramuscolar Use

CLIN-10200-458

Phase 3 small_molecule active

Quick answer

Excipients without active substance - Lyophilised powder for solution for injection - Intramuscolar Use for Treatment of moderate to severe glabellar lines is a Phase 3 program (small_molecule) at Ipsen Pharma with 1 ClinicalTrials.gov record(s).

Program details

Company
Ipsen Pharma
Indication
Treatment of moderate to severe glabellar lines
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials